Viewing Study NCT02685059


Ignite Creation Date: 2025-12-24 @ 3:02 PM
Ignite Modification Date: 2026-02-22 @ 4:14 AM
Study NCT ID: NCT02685059
Status: COMPLETED
Last Update Posted: 2021-02-15
First Post: 2016-01-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Addition of PD-L1 Antibody MEDI4736 to a Taxane-anthracycline Chemotherapy in Triple Negative Breast Cancer
Sponsor: GBG Forschungs GmbH
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None breast cancer View
None Medi4736 View
None Anti PD-L1 View
None Nab-Paclitaxel View
None Placebo View
None triple negative View